Latest Janssen Research & Development LLC Stories
HORSHAM, Pa., March 30, 2015 /PRNewswire/ -- The U.S.
Results served as basis for regulatory filing with U.S.
National Xarelto attorneys at the Onder Law Firm comment on a new Xarelto lawsuit accusing the drugmaker of fraud and negligence for concealing Xarelto's dangers. St.
Independent Data Monitoring Committee determines HELIOS study meets its primary endpoint of progression-free survival in patients with previously treated chronic lymphocytic leukemia/small lymphocytic
NEW YORK, Feb.
Unique Approach Aims to Intercept Disease Prior to Onset and Preserve Health of People At-risk of Developing Type 1 Diabetes RARITAN, N.J., Feb.
New Focus in Disease Prevention, Disease Interception, and the Microbiome to Propel Scientific Innovation RARITAN, N.J., Feb.
RARITAN, N.J., Feb. 3, 2015 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S.
-Seeking profiles in mental health patient advocacy excellence- GHENT, Belgium, Jan. 27, 2015 /PRNewswire/ -- The Museum Dr.
TITUSVILLE, N.J., Jan. 19, 2015 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S.
- A person in a secondary role, specifically the second most important character (after the protagonist).